Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

  • Loading metrics

Personality traits and resilience mediated by depressive symptoms in a sample of psychotherapy patients: A cross-sectional study

  • Leonardo Gonçalves ,

    Contributed equally to this work with: Leonardo Gonçalves, Vitória Maria Tabosa Evaldt, Neusa Sica da Rocha

    Roles Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Software, Writing – original draft, Writing – review & editing

    Affiliations Post Graduate Program in Psychiatry at Federal University of Rio Grande do Sul (UFRGS), Porto Alegre, Rio Grande do Sul, Brazil, Clinical Research Center and Psychiatry Service, I-Qol, Hospital de Clínicas de Porto Alegre (HCPA), Porto Alegre, Rio Grande do Sul, Brazil

  • Vitória Maria Tabosa Evaldt ,

    Contributed equally to this work with: Leonardo Gonçalves, Vitória Maria Tabosa Evaldt, Neusa Sica da Rocha

    Roles Conceptualization, Formal analysis, Writing – original draft, Writing – review & editing

    Affiliations Post Graduate Program in Psychiatry at Federal University of Rio Grande do Sul (UFRGS), Porto Alegre, Rio Grande do Sul, Brazil, Clinical Research Center and Psychiatry Service, I-Qol, Hospital de Clínicas de Porto Alegre (HCPA), Porto Alegre, Rio Grande do Sul, Brazil

  • Neusa Sica da Rocha

    Contributed equally to this work with: Leonardo Gonçalves, Vitória Maria Tabosa Evaldt, Neusa Sica da Rocha

    Roles Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Supervision, Validation, Writing – original draft, Writing – review & editing

    nrocha@hcpa.edu.br

    Affiliation Clinical Research Center and Psychiatry Service, I-Qol, Hospital de Clínicas de Porto Alegre (HCPA), Porto Alegre, Rio Grande do Sul, Brazil

Abstract

Introduction

Resilience is a concept that has been widely studied in different contexts and is related to adaptation to different stress levels. Although research in psychotherapy has produced vast knowledge about the effectiveness and mechanisms that mediate response, there is still no clarity about the role of resilience in this process, especially research in psychotherapy with patients with severe mental illness. Due to the implications of severe mental illness in different areas of life, in these patients, the capacity for resilience may be impaired, and the mechanisms involved in mediating this process are still not well explained.

Objective

Verify the associations between personality traits and resilience and their potential confounders (sociodemographic factors, pharmacological treatment, type of psychotherapy, social support, depressive and anxiety symptoms). Assess depressive symptoms as a possible mediator of the relationship between personality traits and resilience.

Methods

This is a naturalistic cross-sectional study, with 83 participants undergoing psychotherapy from different theoretical lines (psychodynamic, cognitive-behavioural, and interpersonal). Sociodemographic characteristics were evaluated, as well as resilience (25-item Connor Davidson Resilience Scale), depressive symptoms (Beck Depression Inventory), anxious symptoms (Beck Anxiety Inventory), and Personality traits (Personality Inventory for DSM-5).

Results

Resilience was negatively associated with depressive symptoms (B = −12.1, p < 0.001). The mediation effect was significant for depressive symptoms (b = −7.21, BCa 95% CI [−12.6, −3.07]). This variable mediated approximately 46% of the relationship between negative affectivity and resilience.

Conclusion

Resilience was positively associated with antagonism traits and negatively with negative affectivity and depressive symptoms. Depressive symptoms mediated 46% of the relationship between negative affectivity and resilience. The main findings of this study contribute to a greater understanding of the mechanisms involved in resilience, thus influencing the mental health outcomes of patients with severe mental illness.

Introduction

In recent decades, there has been a growing interest in the concept of resilience related to mental health, and extensive literature has been published [1]. The first studies about resilience dated from the 1970s on the development of at-risk children who became healthy adults despite adversity, seeking to understand the risk and protection factors. In the second wave, resilience was understood as a disruption-reintegration process, and the qualities involved in this process were sought [2]. The third and contemporary wave defines resilience as a multidisciplinary construct of a dynamic process of successful adaptation to different stress levels [3].

There is no consensus regarding the definition of the resilience concept, with each research area using its own according to the focus of the study, be it at-risk population such as the military, university students, chronic patients, or in the recovery of trauma victims [4]. Several scales have also been developed in the last few decades to measure resilience and understand its mechanisms in the above mentioned situations. The lack of conceptual standardization has generated criticism regarding the quality and reproducibility of studies, and recently, some authors have proposed a more rigorous methodology for new publications in this field [57].

Despite the extensive literature on the effectiveness and mediating mechanisms of response in the various existing psychotherapies, there is no clarity as to the role of resilience in this process. In recent years, some intervention studies on resilience, with mindfulness and cognitive-behavioral therapy, have shown that they are the most significantly effective [8]. However, there is still a scarcity of longitudinal studies prospectively evaluating the impact of resilience on the mental health of both the clinical and community populations at risk of developing some psychopathology [9,10]. These studies, despite methodological limitations, show that resilience could act as a “buffer” for anxious and depressive symptoms after stressful events in healthy populations. As for clinical populations, we have less data, the majority of which is in the treatment of post-traumatic stress disorder (PTSD) [11].

Resilience has been less studied in the population of patients with severe mental disorders, which refers to patients with chronic mental disorders with high functional impairment [1214]. The association of resilience with clinical measures in hospitalized patients diagnosed with severe mental disorders: major depression, bipolar disorder, and schizophrenia, when comparing resilience levels among these different disorders (schizophrenia, bipolar disorder, and major depression), showed that patients with major depression had lower levels of resilience compared to those diagnosed with the two other disorders [15]. These patients have high rates of unemployment, social isolation, suicide attempts, and psychiatric hospitalizations. They are also exposed to different types of acute and chronic stressors at various levels, resulting in complex psychopathology and greater use of health services. These patients are generally seen in psychiatric outpatient clinics and require combined drug and psychotherapeutic treatments. In this population, where the capacity for resilience seems to be impaired, the processes involved and their mediating mechanisms are not well elucidated [13].

According to Windle, the protective factors related to resilience can be divided into three different levels of functioning: 1) individual, 2) social, and 3) community [16]. In this paper, we focused on individual factors, such as sociodemographic and mainly psychological or intrapsychic (personality traits) factors, and social or external factors, such as social support and social stressors, by involving patients in psychotherapeutic treatment. Other factors related to resilience were included, such as the type of psychotherapy and pharmacological treatment.

The main objective of this study is to verify the associations between personality traits and resilience and their potential confounders (sociodemographic factors, pharmacological treatment, type of psychotherapy, social support, depressive and anxiety symptoms). The secondary objective is to assess depressive symptoms as a possible mediator of the relationship between personality traits and resilience.

Primary hypothesis: there is a positive association between personality traits and resilience. Anxious and depressive symptoms may mediate this association. Higher levels of depressive and anxiety symptoms and psychosocial stressors are associated with lower levels of resilience.

Secondary hypothesis: Older age, higher levels of education, and male gender are associated with higher levels of resilience. More significant social support, pharmacological treatment, and cognitive-behavioral therapy are also associated with higher levels of resilience.

Methods

This study is part of a larger project called Longitudinal Investigation of Psychotherapy Outcomes (LIPO), and its research protocol has been described in greater detail elsewhere [17].

Design

The present study is a naturalistic cross-sectional study, and its population corresponds to the baseline sample of the larger project mentioned above. The primary study is a longitudinal observational study with a 12-month follow-up (baseline, 06 months, and 12 months) of outpatient follow-up in three types of psychotherapy: psychodynamic psychotherapy (PDT), cognitive-behavioral psychotherapy (CBT), and interpersonal psychotherapy (IPT). The data were collected between March 2015 and December 2017.

Sample and procedures

The sample of this study is composed of 83 patients who underwent one of three evidence-based modalities of individual psychotherapy [psychodynamic psychotherapy (PDT), interpersonal psychotherapy (IPT), and cognitive–behavioral psychotherapy (CBT)], with age above 18 years old who started the psychotherapy within one month and had a Beck Depression Inventory (BDI) score greater than 15. Patients with psychotic disorders, in current use of psychoactive substances (alcohol, cocaine, marijuana. etc.), cognitive deficits, and dementias were excluded. This sample corresponds to outpatients referred from a screening outpatient clinic that attends the other clinical outpatients of a general hospital (Hospital de Clínicas de Porto Alegre).

Indication of the psychotherapy modality considered previous favorable experience with some psychotherapy, psychological-mindedness, presence of personality disorder or traits, number of diagnoses of psychiatric disorders, and relief of symptoms. When diagnosed with a personality disorder associated with one or more major psychiatric disorders and psychological-mindedness, PDT was indicated. When there are up to two primary psychiatric diagnoses without personality disorder, it will be directed to CBT as well as in the exclusive quest for symptom relief. When the focus of the problem was exclusively up to two of the following: 1) dispute, 2) roles dispute, 3) role transition, or 4) interpersonal deficits and no personality disorder, IPT was indicated. Psychiatry residents provided psychotherapies under weekly supervision.

Instruments

Resilience.

Connor-Davidson Resilience Scale (CD-RISC) developed by Connor & Davidson: measures levels of positive psychosocial adaptation in the face of significant life events. Comprises 25 items with a Likert response ranging from 0, “not at all true,” to 4, “almost always true” [18].

Personality.

The Personality Inventory for DSM-5 (Diagnostic and Statistical Manual of Mental Disorders) (PID-5) – Adult. A set of 25 core elements of personality description that combine into five broad domains of maladaptive personality variation: negative affect, detachment, antagonism, disinhibition, and psychoticism [19].

Psychosocial stressors.

Life Events Questionnaire (LEQ): assesses the occurrence of 14 stressful life events in the last 12 months, their impact on the subject’s life, and the association with the onset of current psychiatric problems [20].

Symptoms of anxiety and depression.

Beck Depression Inventory (BDI) and Beck Anxiety Inventory (BAI): They are self-report scales of the magnitude of depression (BDI) and anxiety (BAI) developed by Beck, aiming to evaluate levels of anxiety, suicidal ideation, and depression [21].

Social support.

Social Support Questionnaire of the MOS Study: This questionnaire was developed to assess the social support received by patients with chronic diseases and adapted to Portuguese [22]. It consists of 19 self-report items and a Likert format with a score of 1–5, in which the higher the score, the greater the social support [23,24].

Statistical analysis

Continuous sociodemographic variables were presented as means and standard deviations (SD), and categorical variables were presented as percentages. Pearson’s bivariate correlation was used for the correlation test, and linear regression with the backward method was used for multivariate analyses. Factors that had a previous association with resilience, according to the literature, were included in the statistical model: sociodemographic [25], social support [26,27], pharmacological treatment [11,28], type of psychotherapy [8,29], psychosocial stressors [10], depressive and anxiety symptoms [3032] and personality traits [3336]. The level of significance was set at p < 0.05.

The mediation analysis was performed with the statistically significant factors obtained in the logistic regression using the bootstrapping method described by Preacher and Hayes [37], To understand the impact of personality traits on resilience (negative affectivity), a mediation analysis was performed using depressive symptoms as a mediator, as they are a state variable. To understand the finding of the antagonism trait positively impacting resilience, a multivariate regression analysis was performed using only the facets of this trait to determine which ones influenced resilience.

All analyses were performed using SPSS version 21.

Ethical aspects

As previously mentioned, this study is part of the LIPO project, approved by the Research Ethics Committee of Hospital de Clínicas de Porto Alegre (GPPC—HCPA number 150097). All study participants signed an informed consent form outlining the study’s objectives. No research team members participated in the clinical and psychotherapeutic treatment of patients.

Results

Table 1 shows the characteristics of the sample. Furthermore, in relation to psychotherapeutic treatments, the main indication for psychotherapy was for PDT (57.8%), with more than double that of the second, which was CBT (24.1%), and lastly, IPT (18.1%). It is noteworthy the high prevalence of medication use (90%) as well as suicide attempts (39.4%) and recent psychiatric hospitalization (28.2%), denoting a severe clinical population. Furthermore, the total CD-RISC mean score was 49.85 (SD:17.6), and the mean depression score, evaluated with BDI, was 30.43 (SD: 10.78).

There was a positive correlation between resilience and social support (r = 0.321, p = 0.001), but no correlation was found between resilience and the stressors scale (r = 0.02, p = 0.66). We found a high negative correlation with depressive (r = −0.57, p = 0.01), anxious symptoms (r = −0.46, p = 0.01), and negative affectivity (r = −0.48, p = 0.01).

In the multivariate analysis (Table 2), factors with p ≤ 0.05 of the bivariate correlation analysis were inserted in the model (gender, suicide attempt, pharmacological treatment, depressive symptoms, anxiety symptoms, social support, negative affectivity, detachment and disinhibition). A statistically significant positive association was found with the trait of antagonism (B = 7.67, p = 0.006). Resilience was negatively associated with depressive symptoms (B = −0.5, p = 0.004) and negative affectivity (B = −12.1, p < 0.001). There was a positive association trend with pharmacological treatment, but without reaching statistical significance (B = 9.7, p = 0.07). The proportion of adjusted variability of resilience explained by the final model was 52% (R2adj 0.52, p = 0.001).

thumbnail
Table 2. Multivariate adjustment of significant factors from the bivariate analysis associated with resilience.

https://doi.org/10.1371/journal.pone.0327846.t002

Fig 1 shows that depressive symptoms [BDI] (b = −7.32, BCa Cl 95% [−12.6, −3.07]) were significant mediators, explaining approximately 46% of the relationship between negative affectivity [PID-5] and resilience [CD-RISC]. Only the grandiosity facet was significant (B = 7.29, p = 0.038). The other facets (dishonesty, seeking attention, manipulation, and insensitivity) did not show a significant association.

thumbnail
Fig 1. Negative affectivity as a predictor of resilience mediated by depressive symptoms.

(A) The Bias-Corrected and Accelerated (Bca) confidence interval was estimated using Boostraping technique (5,000 resamples) (B) All coefficients represent unstandardized beta coefficients (standard errors in parentheses) (C) *p < 0.001.

https://doi.org/10.1371/journal.pone.0327846.g001

Discussion

Primary findings

This is the first study to our knowledge that investigates the factors associated with resilience in outpatients with severe mental disorders using different methods of psychotherapy (PDT, CBT, and IPT). The main objective of this study was to examine the association between personality factors and resilience. A negative association was found between negative affectivity and resilience, and a positive association between antagonism and resilience.

The PID-5 negative affectivity domain is analogous to the Big Five neuroticism construct in non-clinical populations and relates to the experience of negative emotions, including a study showing activation patterns in different regions of the neocortex than in a healthy population [38,39]. Both are associated as a risk factor for the development of depressive and anxious psychopathology in several studies [3436,40,41]. It is not surprising that we find in a population of chronically ill patients the impact that this facet of personality can have on their ability to deal with various forms of stress, especially disorders such as depression, resulting in a reduced perception of resilience and, therefore, mitigation of these conditions and restoring their basal functioning, which would be a successful process for someone resilient [3,15].

This is evident with the mean level of resilience of this population of 49.85, comparable with other studies with clinical samples [42,43] but much lower than that of community populations with an average that varied between some studies compiled by the scale’s developers between 65.4 and 80.4 in different countries. In the work by Solano (2012) with a Brazilian sample of 108 outpatients, a mean value of 57.7 was found for patients with anxious symptoms and 52.1 for patients with borderline personality disorder [43]. Min et al. (2013) found values of 47.4 (20.2) in 230 outpatients with anxiety and depression [44], and Um et al. (2014) reported a mean of 46.0 (20.8) for 254 outpatients with depression [45]. A more recent study showed that patients with major depression have lower levels of resilience than even patients with schizophrenia and bipolar disorder [15].

In addition, we found an unprecedented association in the literature of the PID-5 antagonism domain on resilience. To understand this result, we analysed the facets that comprise the antagonism trait and found only grandiosity as a predictor of resilience. This finding might be, unfortunately, a result of a distorted view of these patients regarding their resilience. In the study by Nunes (2022), with inpatients but with a similar profile of high severity, it was found that resilience was comparatively lower in depressed patients compared to patients with schizophrenia and bipolar mood disorder [15].

Secondary findings

To understand the relationship between trait and state, a mediation analysis was performed to clarify how much of the perception of patients in the sample of patients with negative affectivity influenced their resilience through their depressive symptomatology. It was observed that approximately 46% of this relationship was mediated by the depressive state (depressive symptoms). This result shows a complex interrelationship between personality (trait), symptomatology (state), and resilience, impacting overall mental health. Some authors consider that resilience could act as a buffer for the adverse effects of personality on symptoms of depression and anxiety [11].

For other factors that have already been extensively studied, such as social support and the level of psychosocial stressors, we found a positive correlation between resilience and social support. We had no statistically significant association with live stressors. The type of psychotherapy assigned was also not associated with the level of resilience.

This work sought to establish relevant study factors to be researched in assessing contributors to resilience in clinical populations with chronic and severe disorders. The field of resilience has developed mainly in the investigation of factors that protect mental disorders in populations at risk, such as health professionals, police, students and athletes [4]; however, it lacks a better understanding of the factors that may promote the restoration of at least partial resilience capacity in populations that already have functional chronic impairment and that are possibly unable to return to functioning at a healthy level, resulting in a lossy or dysfunctional reintegration [3]. By understanding the factors that promote resilience more effectively and those that reduce it, we can establish more specific interventions in psychotherapy, advancing not only in relieving symptoms.

Limitations

This study has some limitations. This is a cross-sectional analysis of a baseline sample from a more extensive longitudinal study [17] with a 12-month follow-up, so it is impossible to infer causality in the associations found between negative affectivity, antagonism, depressive symptoms, and resilience. The generalization of its results to other populations is also limited. The sample studied, being evaluated in tertiary-level psychiatric outpatient clinics, is characterized by presenting what the World Health Organization considers as a severe mental disorder (SMD), that is, patients with high levels of psychopathology, a high number of suicide attempts, and hospitalizations. The field of resilience has been less focused on the investigation of populations with chronic mental disorders, where the capacity for resilience is reduced, so we believe that research on mechanisms that enable the promotion of resilience in patients with high demand for mental health services is valid.

There still needs to be more consensus in the literature regarding the definition of resilience or how best to evaluate it [4,16,46]. Several instruments aim to measure resilience with good psychometric properties without a gold standard [47]. CD-RISC was used because it was developed in patients with PTSD, which is like the severity of our sample, and because it is more sensitive to change due to treatment since this study is the baseline sample of a longitudinal study [17]. Other authors argue that questionnaires measure factors linked to resilience but not their underlying mechanisms [7,48]. They propose that resilience be measured quantitatively in longitudinal studies through the ratio of the load of mental health problems to the load of stressors [7]. Patients who presented no or minimal worsening of symptoms after one or more stressors would be resilient [48]. Studies of this nature require several measures over time, which makes them highly challenging. Measuring stressors in chronically ill patients becomes difficult, as there is no clear separation between the effect of the stressor and the onset of symptoms. In addition, self-administered questionnaires may present biases related to social desirability and memory bias, so there is still a lack of more objective measures of resilience.

Future directions

The analysis of this sample’s follow-up may clarify the direction of the causality of the associations between negative affectivity, antagonism, depressive symptoms, and resilience shown in this study.

Conclusion

The present work showed significant associations between personality traits of negative affectivity and antagonism and depressive symptoms and social support with resilience. Depressive symptoms mediated nearly half the relationship between negative affectivity and resilience. These findings contribute to a greater understanding of both the mechanisms that promote resilience and those that can reduce it, thus influencing the mental health outcomes of outpatients in different psychotherapies.

Supporting information

S1 Protocol. Description of the study protocol, April-2019.

https://doi.org/10.1371/journal.pone.0327846.s001

(PDF)

S2 Database. Partial database including the main data of the mentioned instruments.

https://doi.org/10.1371/journal.pone.0327846.s002

(XLSX)

References

  1. 1. Bonanno GA, Romero SA, Klein SI. The temporal elements of psychological resilience: an integrative framework for the study of individuals, families, and communities. Psychol Inquiry. 2015;26(2):139–69.
  2. 2. Bonanno GA. Loss, trauma, and human resilience: have we underestimated the human capacity to thrive after extremely aversive events?. Am Psychol. 2004;59(1):20–8. pmid:14736317
  3. 3. Richardson GE. The metatheory of resilience and resiliency. J Clin Psychol. 2002;58(3):307–21. pmid:11836712
  4. 4. Fletcher D, Sarkar M. Psychological resilience: a review and critique of definitions, concepts, and theory. Eur Psychol. 2013;18(1):12–23.
  5. 5. Chmitorz A, Kunzler A, Helmreich I, Tüscher O, Kalisch R, Kubiak T, et al. Intervention studies to foster resilience - A systematic review and proposal for a resilience framework in future intervention studies. Clin Psychol Rev. 2018;59:78–100. pmid:29167029
  6. 6. Forbes S, Fikretoglu D. Building resilience: the conceptual basis and research evidence for resilience training programs. Rev Gen Psychol. 2018;22(4):452–68.
  7. 7. Kalisch R, Müller MB, Tüscher O. A conceptual framework for the neurobiological study of resilience. Behav Brain Sci. 2015;38:e92. pmid:25158686
  8. 8. Joyce S, Shand F, Tighe J, Laurent SJ, Bryant RA, Harvey SB. Road to resilience: a systematic review and meta-analysis of resilience training programmes and interventions. BMJ Open. 2018;8(6):e017858. pmid:29903782
  9. 9. Hjemdal O, Friborg O, Stiles TC, Rosenvinge JH, Martinussen M. Resilience predicting psychiatric symptoms: a prospective study of protective factors and their role in adjustment to stressful life events. Clin Psychol Psychother. 2006;13(3):194–201.
  10. 10. Sheerin CM, Lind MJ, Brown EA, Gardner CO, Kendler KS, Amstadter AB. The impact of resilience and subsequent stressful life events on MDD and GAD. Depress Anxiety. 2018;35(2):140–7. pmid:29172241
  11. 11. Davidson J, Stein DJ, Rothbaum BO, Pedersen R, Szumski A, Baldwin DS. Resilience as a predictor of treatment response in patients with posttraumatic stress disorder treated with venlafaxine extended release or placebo. J Psychopharmacol. 2012;26(6):778–83. pmid:21926426
  12. 12. Johnson DL. Overview of severe mental illness. Clin Psychol Rev. 1997;17(3):247–57. pmid:9160175
  13. 13. Parabiaghi A, Bonetto C, Ruggeri M, Lasalvia A, Leese M. Severe and persistent mental illness: a useful definition for prioritizing community-based mental health service interventions. Soc Psychiatry Psychiatr Epidemiol. 2006;41(6):457–63. pmid:16565917
  14. 14. Ruggeri M, Leese M, Thornicroft G, Bisoffi G, Tansella M. Definition and prevalence of severe and persistent mental illness. Br J Psychiatry. 2000;177:149–55. pmid:11026955
  15. 15. Nunes KG, da Rocha NS. Resilience in severe mental disorders: correlations to clinical measures and quality of life in hospitalized patients with major depression, bipolar disorder, and schizophrenia. Qual Life Res. 2022;31(2):507–16. pmid:34173172
  16. 16. Windle G. What is resilience? A review and concept analysis. Rev Clin Gerontol. 2010;21(2):152–69.
  17. 17. Gonçalves L, Barbisan GK, Rebouças CDAV, da Rocha NS. Longitudinal Investigation of Psychotherapy Outcomes (LIPO): Description of the Study Protocol. Front Psychiatry. 2019;10:212. pmid:31024364
  18. 18. Connor KM, Davidson JRT. Development of a new resilience scale: the Connor-Davidson Resilience Scale (CD-RISC). Depress Anxiety. 2003;18(2):76–82. pmid:12964174
  19. 19. Quilty LC, Ayearst L, Chmielewski M, Pollock BG, Bagby RM. The psychometric properties of the personality inventory for DSM-5 in an APA DSM-5 field trial sample. Assessment. 2013;20(3):362–9. pmid:23588687
  20. 20. Tennant C, Andrews G. A scale to measure the cause of life events. Aust N Z J Psychiatry. 1977;11(3):163–7. pmid:270333
  21. 21. Cunha J. Manual da versão em português das Escalas Beck. São Paulo: Casa do Psicólogo; 2001.
  22. 22. Chor D, Griep RH, Lopes CS, Faerstein E. Social network and social support measures from the Pró-Saúde Study: pre-tests and pilot study. Cad Saude Publica. 2001;17(4):887–96. pmid:11514869
  23. 23. Griep RH, Chor D, Faerstein E, Werneck GL, Lopes CS. Validade de constructo de escala de apoio social do Medical Outcomes Study adaptada para o português no Estudo Pró-Saúde. Cadernos de Saúde Pública. 2005;21:703–14.
  24. 24. Sherbourne CD, Stewart AL. The MOS social support survey. Soc Sci Med. 1991;32(6):705–14. pmid:2035047
  25. 25. Campbell-Sills L, Forde DR, Stein MB. Demographic and childhood environmental predictors of resilience in a community sample. J Psychiatr Res. 2009;43(12):1007–12. pmid:19264325
  26. 26. Ozbay F, Johnson DC, Dimoulas E, Morgan CA, Charney D, Southwick S. Social support and resilience to stress: from neurobiology to clinical practice. Psychiatry (Edgmont). 2007;4(5):35–40. pmid:20806028
  27. 27. Zhang H, Zhao Q, Cao P, Ren G. Resilience and quality of life: exploring the mediator role of social support in patients with breast cancer. Med Sci Monit. 2017;23:5969–79. pmid:29248937
  28. 28. Davidson J, Baldwin DS, Stein DJ, Pedersen R, Ahmed S, Musgnung J, et al. Effects of venlafaxine extended release on resilience in posttraumatic stress disorder: an item analysis of the Connor-Davidson Resilience Scale. Int Clin Psychopharmacol. 2008;23(5):299–303. pmid:18703940
  29. 29. Helmreich I, Kunzler A, Chmitorz A, König J, Binder H, Wessa M, et al. Psychological interventions for resilience enhancement in adults. Cochrane Database Syst Rev. 2017;2017(2).
  30. 30. Gong Y, Shi J, Ding H, Zhang M, Kang C, Wang K, et al. Personality traits and depressive symptoms: The moderating and mediating effects of resilience in Chinese adolescents. J Affect Disord. 2020;265:611–7. pmid:31787420
  31. 31. Hjemdal O, Vogel PA, Solem S, Hagen K, Stiles TC, Wiley J. The relationship between resilience and levels of anxiety, depression, and obsessive-compulsive symptoms in adolescents. Clin Psychol Psychother. 2011;18(4):314–21. pmid:20806419
  32. 32. Mosqueiro BP, da Rocha NS, Fleck MP de A. Intrinsic religiosity, resilience, quality of life, and suicide risk in depressed inpatients. J Affect Disord. 2015;179:128–33. pmid:25863908
  33. 33. Campbell-Sills L, Cohan SL, Stein MB. Relationship of resilience to personality, coping, and psychiatric symptoms in young adults. Behav Res Ther. 2006;44(4):585–99. pmid:15998508
  34. 34. Oshio A, Taku K, Hirano M, Saeed G. Resilience and Big Five personality traits: A meta-analysis. Pers Individ Diff. 2018;127:54–60.
  35. 35. Sarubin N, Wolf M, Giegling I, Hilbert S, Naumann F, Gutt D, et al. Neuroticism and extraversion as mediators between positive/negative life events and resilience. Pers Individ Diff. 2015;82:193–8.
  36. 36. Zager Kocjan G, Kavčič T, Avsec A. Resilience matters: Explaining the association between personality and psychological functioning during the COVID-19 pandemic. Int J Clin Health Psychol. 2021;21(1):100198. pmid:33363581
  37. 37. Hayes AF. Introduction to mediation, moderation, and conditional process analysis: A regression-based approach. Guilford Press; 2018.
  38. 38. Gore WL. The DSM-5 Dimensional Trait Model and the Five Factor Model. University of Kentucky; 2013. Available from: https://uknowledge.uky.edu/psychology_etds/12
  39. 39. Steffens DC, Wang L, Manning KJ, Pearlson GD. Negative affectivity, aging, and depression: results from the Neurobiology of Late-Life Depression (NBOLD) Study. Am J Geriatr Psychiatry. 2017;25(10):1135–49. pmid:28457805
  40. 40. Lü W, Wang Z, Liu Y, Zhang H. Resilience as a mediator between extraversion, neuroticism and happiness, positive affect and negative affect. Pers Individ Dif. 2014;63:128–33.
  41. 41. Londero I, da Rocha NS. Personality dimensions, resilience, and depression during COVID-19 pandemic: a one-year longitudinal study. Acta Psychol. 2024;245:104229.
  42. 42. Davidson C. Connor-Davidson Resilience Scale (CD-RISC) Manual. [Internet]. 2018. Available from: https://www.connordavidson-resiliencescale.com/CD-RISC%20Manual%2008-19-18.pdf
  43. 43. Solano JPC, Bracher ESB, Faisal-Cury A, Ashmawi HA, Carmona MJC, Lotufo-Neto F, et al. Factor structure and psychometric properties of the Connor-Davidson resilience scale among Brazilian adult patients. Sao Paulo Med J. 2016;134(5):400–6. pmid:27191249
  44. 44. Min J-A, Jung Y-E, Kim D-J, Yim H-W, Kim J-J, Kim T-S, et al. Characteristics associated with low resilience in patients with depression and/or anxiety disorders. Qual Life Res. 2013;22(2):231–41. pmid:22485024
  45. 45. Um Y-H, Huh H-J, Kim S-Y, Chae J-H. Possible cultural effects on the increments of somatic symptoms in subjectively resilient depressed patients. Asia Pac Psychiatry. 2014;6(3):259–66. pmid:25103955
  46. 46. Aburn G, Gott M, Hoare K. What is resilience? An Integrative Review of the empirical literature. J Adv Nurs. 2016;72(5):980–1000. pmid:26748456
  47. 47. Windle G, Bennett KM, Noyes J. A methodological review of resilience measurement scales. Health Qual Life Outcomes. 2011;9:8. pmid:21294858
  48. 48. Kalisch R, Baker DG, Basten U, Boks MP, Bonanno GA, Brummelman E, et al. The resilience framework as a strategy to combat stress-related disorders. Nat Hum Behav. 2017;1(11):784–90. pmid:31024125